Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry

Connect® MM Registry

doi:10.1038/s41408-021-00524-1

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect^® MM Registry

Connect® MM Registry

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Article number	134
Journal	Blood Cancer Journal
Volume	11
Issue number	7
DOIs	https://doi.org/10.1038/s41408-021-00524-1
State	Published - Jul 2021

Access to Document

10.1038/s41408-021-00524-1

Cite this

@article{e5f12042c8a14cf4b6dcb5665095ba82,

title = "Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect{\textregistered} MM Registry",

author = "{Connect{\textregistered} MM Registry} and Lee, {Hans C.} and Sikander Ailawadhi and Gasparetto, {Cristina J.} and Sundar Jagannath and Rifkin, {Robert M.} and Durie, {Brian G.M.} and Mohit Narang and Terebelo, {Howard R.} and Kathleen Toomey and Hardin, {James W.} and Lynne Wagner and Omel, {James L.} and Mazaher Dhalla and Liang Liu and Prashant Joshi and Rafat Abonour and Rafat Abonour",

note = "Funding Information: The authors would like to thank all the patients and their families, nurses, study personnel, and investigators who participated in the Connect MM{\textregistered}Registry. We would like to acknowledge Lihua Yue, Bristol Myers Squibb, Princeton, NJ, USA, for statistical support. We would also like to acknowledge Jane Lu and Jay Cao, Bristol Myers Squibb, Princeton, NJ, USA, for programming support. This study was supported by Celgene, Bristol-Myers Squibb. This paper was written on behalf of the Connect MM Registry Investigators. All authors contributed to the acquisition, analysis, or interpretation of data and drafts of the article; revised the paper critically for important intellectual content; approved the final version to be published; and agreed to be accountable for all aspects of the article. The authors received writing and editorial assistance from Alessandra Richardson, PhD, from Bio Connections LLC, funded by Bristol Myers Squibb. Funding Information: Myers Squibb; L.L. employment at Bristol Myers Squibb; P.J. employment at Bristol Myers Squibb; R.A. steering committee member for and research funding from Celgene, a Bristol Myers Squibb Company, and Takeda; research funding for Prothena.",

year = "2021",

month = jul,

doi = "10.1038/s41408-021-00524-1",

language = "English",

volume = "11",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma

T2 - results from the Connect® MM Registry

AU - Connect® MM Registry

AU - Lee, Hans C.

AU - Ailawadhi, Sikander

AU - Gasparetto, Cristina J.

AU - Jagannath, Sundar

AU - Rifkin, Robert M.

AU - Durie, Brian G.M.

AU - Narang, Mohit

AU - Terebelo, Howard R.

AU - Toomey, Kathleen

AU - Hardin, James W.

AU - Wagner, Lynne

AU - Omel, James L.

AU - Dhalla, Mazaher

AU - Liu, Liang

AU - Joshi, Prashant

AU - Abonour, Rafat

N1 - Funding Information: The authors would like to thank all the patients and their families, nurses, study personnel, and investigators who participated in the Connect MM®Registry. We would like to acknowledge Lihua Yue, Bristol Myers Squibb, Princeton, NJ, USA, for statistical support. We would also like to acknowledge Jane Lu and Jay Cao, Bristol Myers Squibb, Princeton, NJ, USA, for programming support. This study was supported by Celgene, Bristol-Myers Squibb. This paper was written on behalf of the Connect MM Registry Investigators. All authors contributed to the acquisition, analysis, or interpretation of data and drafts of the article; revised the paper critically for important intellectual content; approved the final version to be published; and agreed to be accountable for all aspects of the article. The authors received writing and editorial assistance from Alessandra Richardson, PhD, from Bio Connections LLC, funded by Bristol Myers Squibb. Funding Information: Myers Squibb; L.L. employment at Bristol Myers Squibb; P.J. employment at Bristol Myers Squibb; R.A. steering committee member for and research funding from Celgene, a Bristol Myers Squibb Company, and Takeda; research funding for Prothena.

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85112256313&partnerID=8YFLogxK

U2 - 10.1038/s41408-021-00524-1

DO - 10.1038/s41408-021-00524-1

M3 - Letter

C2 - 34301916

AN - SCOPUS:85112256313

SN - 2044-5385

VL - 11

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 7

M1 - 134

ER -